Home > > > Endoscopy Devices Market Share & Industry Statistics 2025-2033

Endoscopy Devices Market Share & Industry Statistics 2025-2033

Author : harry joe | Published On : 18 Nov 2025

The global endoscopy devices market was valued at USD 50.01 Billion in 2024 and is projected to reach USD 85.93 Billion by 2033, exhibiting a CAGR of 5.58% during the 2025-2033 forecast period. Growing adoption of minimally invasive surgeries, rising prevalence of gastrointestinal diseases and cancer, and continual technological advancements are driving this growth. The endoscopy devices market share is expanding rapidly due to increasing demand for minimally invasive diagnostic and therapeutic procedures and growing awareness about early disease detection. Endoscopy devices, designed for visualizing internal organs through small incisions or natural body openings, are widely recognized for their precision, reduced recovery times, and lower risk of complications compared to traditional surgical methods. Aging populations, increasing prevalence of chronic diseases, and technological innovations including high-definition imaging, 3D visualization, and AI-assisted diagnostics are fueling global demand. Manufacturers are introducing advanced variants including flexible and rigid endoscopes, capsule endoscopes, robot-assisted systems, and disposable endoscopes to attract a wider market. Additionally, the expansion of outpatient care facilities and the growing emphasis on infection prevention are expected to further boost the global endoscopy devices market size over the forecast period.

Study Assumption Years

  • Base Year: 2024
  • Historical Year/Period: 2019-2024
  • Forecast Year/Period: 2025-2033

Endoscopy Devices Market Key Takeaways

  • Current Market Size: USD 50.01 Billion (2024)
  • CAGR: 5.58% (2025-2033)
  • Forecast Period: 2025-2033
  • The market is estimated to reach USD 85.93 Billion by 2033.
  • North America dominates with over 38.6% market share in 2024, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and favorable reimbursement policies.
  • Endoscopy visualization systems are the leading product segment with 41.5% market share, while endoscopes remain the fastest-growing category.
  • Gastrointestinal endoscopy dominates by application, with hospitals and clinics as the largest end-user segment.
  • Market growth is supported by expanding minimally invasive procedures, technological innovations, increasing geriatric population, and growing demand for disposable endoscopes.

Request to Get the Sample Report: https://www.imarcgroup.com/endoscopy-devices-market/requestsample

Market Growth Factors

The endoscopy devices market is being propelled by rising demand for minimally invasive surgical techniques, increasing prevalence of chronic diseases, and technological breakthroughs in imaging systems. Healthcare providers and patients are increasingly shifting to endoscopic procedures as alternatives to traditional open surgeries, due to benefits including faster recovery times, reduced postoperative pain, shorter hospital stays, smaller incisions, reduced blood loss, and lower infection risks. Endoscopy's precision, real-time visualization capabilities, and therapeutic intervention options make it a preferred choice for medical professionals seeking optimal patient outcomes. The introduction of diverse endoscopic technologies—high-definition cameras, 4K and 3D imaging systems, narrow-band imaging, capsule endoscopy, robot-assisted platforms, and AI-powered diagnostic tools—caters to evolving clinical needs and is expanding the demographic and geographic reach of endoscopy applications globally.

The global burden of gastrointestinal disorders, cancer, respiratory diseases, and urological conditions continues to escalate, supporting endoscopy market growth. The American Cancer Society projects 1,958,310 new cancer cases in the United States in 2023, while gastrointestinal endoscopies in the U.S. exceed 75 million procedures annually, including over 19 million colonoscopies. Endoscopy's critical role in early detection, diagnosis, and treatment of these conditions—offering superior visualization compared to traditional methods—aligns with healthcare systems' focus on preventive care and improved patient outcomes. The market growth is further spurred by innovations in disposable endoscopes addressing infection control concerns, advanced capsule technologies enabling non-invasive examinations, and AI-assisted systems providing real-time polyp detection and diagnostic accuracy enhancements, meeting requirements of both large hospital systems and specialized outpatient facilities.

Endoscopy's minimally invasive nature compared to conventional surgery—requiring minimal incisions, generating significantly less trauma, enabling same-day discharge in many procedures, and offering faster return to normal activities—aligns with patient preferences and healthcare cost-containment initiatives. The wide presence of endoscopic procedures in hospitals, ambulatory surgical centers, and specialized endoscopy units, coupled with physician training programs and favorable reimbursement frameworks, has made endoscopy easier to incorporate into standard medical practice. Industry leaders regularly demonstrate procedural advances and clinical benefits, inspiring broader adoption among healthcare providers. Healthcare facilities have improved endoscopy accessibility through dedicated endoscopy suites, state-of-the-art equipment investments, and specialized endoscopy centers, supporting market expansion.

Another contributor is the increased adoption of endoscopy for bariatric procedures, obesity management, and chronic disease prevention. Over 280,000 metabolic and bariatric surgeries were performed in the United States in 2022, with endoscopic sleeve gastroplasty—a non-surgical procedure using sutures to reduce stomach size by 70%—gaining significant traction. Endoscopy's cost-effectiveness, shorter procedure times, and excellent safety profile fit well within value-based care models and population health management strategies. The growing geriatric population, which is more susceptible to age-related diseases requiring endoscopic interventions, represents a substantial demographic driver. Technological convergence of endoscopy with artificial intelligence, cloud computing, robotics, and advanced materials science is creating unprecedented capabilities for precision medicine and personalized treatment approaches.

Buy Now: https://www.imarcgroup.com/checkout?id=3835&method=1670

Market Segmentation

  • Type:
  • Endoscopes: Rapidly growing segment encompassing flexible endoscopes (for gastrointestinal, bronchoscopy, and other internal examinations), rigid endoscopes (for laparoscopy, arthroscopy, and surgical procedures), capsule endoscopes (wireless ingestible cameras for intestinal examination), and robot-assisted endoscopes (providing enhanced maneuverability and precision); valued for direct visualization and therapeutic intervention capabilities.
  • Endoscopy Visualization Systems: Dominates the market with 41.5% share due to importance in improving diagnostic and therapeutic accuracy; includes high-definition cameras, 4K and 3D imaging systems, video processors, display monitors, and LED light sources; critical for accurate identification and treatment of medical conditions.
  • Endoscopy Visualization Components: Supporting segment including imaging sensors, light guides, optical components, and camera heads that enable high-quality visualization during procedures.
  • Operative Devices: Encompasses endoscopic instruments and accessories such as biopsy forceps, graspers, scissors, snares, retrieval devices, suction systems, and specialized therapeutic tools used during endoscopic procedures.
  • Application:
  • Gastrointestinal Endoscopy: Leads the market by application due to high prevalence of gastrointestinal diseases, colorectal cancer screening programs, and increased awareness about early-stage diagnosis; includes upper GI endoscopy, colonoscopy, and ERCP procedures.
  • Laparoscopy: Major segment for minimally invasive abdominal and pelvic surgeries; widely adopted across general surgery, gynecology, and urology specialties.
  • Arthroscopy: Growing application for joint examination and minimally invasive orthopedic procedures, particularly for knee, shoulder, and hip surgeries.
  • Urology Endoscopy: Expanding segment for kidney stone management, bladder examinations, and urological interventions using cystoscopes and ureteroscopes.
  • Gynecology Endoscopy: Important application for hysteroscopy, diagnostic procedures, and minimally invasive gynecological surgeries.
  • Bronchoscopy: Critical for respiratory system examination, lung cancer diagnosis, and pulmonary interventions.
  • Others: Includes ENT endoscopy, neuroendoscopy, and other specialized applications.
  • End Use:
  • Hospitals and Clinics: Largest segment driven by comprehensive endoscopy facilities, state-of-the-art equipment, specialized endoscopy suites, and high patient volumes requiring diagnostic and therapeutic procedures.
  • Ambulatory Surgical Centers (ASCs): Fastest-growing segment reflecting shift toward outpatient care, cost-effective procedures, convenient same-day discharge options, and growing number of specialized endoscopy centers.
  • Others: Includes diagnostic centers, specialty clinics, and academic medical centers.

Regional Insights

North America currently dominates the market with over 38.6% market share in 2024, driven by advanced healthcare infrastructure, high healthcare expenditure, strong adoption of innovative technologies, favorable reimbursement policies, and robust regulatory frameworks supporting device approvals. The United States accounts for the majority of regional revenue, with the U.S. endoscopy devices market valued at USD 11.6 Billion in 2024 and projected to reach USD 21 Billion by 2033 at a CAGR of 6.8%. The region's dominance is attributed to high prevalence of chronic diseases, increasing cancer screening programs, well-established physician training programs, early adoption of next-generation imaging systems including AI-assisted diagnostics, and strong presence of leading manufacturers driving continuous innovation.

Recent Developments & News

  • December 2024: AIG Hospital in Hyderabad announced adoption of PillBot, a disposable endoscopy device with miniature camera and sensors; clinical trials expected to be reviewed by U.S. FDA in 2025 with global market entry projected for 2026.
  • December 2024: Sotelix Endoscopy announced closure of $1.7 million in seed round financing to advance endoscopic technologies.
  • December 2024: Odin Medical Ltd., an Olympus company, received U.S. FDA 510(k) clearance for CADDIE computer-aided detection device, the first cloud-based AI technology for colorectal polyp detection during colonoscopy.
  • October 2024: Olympus Corporation, in collaboration with Odin Medical, earned CE clearance for three cloud-AI-based medical devices: CADDIE, CADU, and SMARTIBD, advancing toward complete AI-powered endoscopy ecosystem.
  • September 2024: Olympus received U.S. FDA 510(k) approval for CADDIE (CADe) device, cloud-based AI technology assisting gastroenterologists in detecting colorectal polyps during colonoscopy procedures.
  • September 2024: Olympus Latin America launched EVIS X1 endoscopy system in Brazil, featuring advanced imaging technologies including Texture and Color Enhancement and Narrow Band Imaging.
  • August 2024: Ambu received CE mark approval for next-generation duodenoscopy solutions, Ambu aBox 2 and Ambu aScope Duodeno 2, for ERCP procedures.
  • May 2025: Olympus received FDA 510(k) clearance for EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology for enhanced visualization and diagnostic precision.
  • April 2025: FUJIFILM announced commercial launch of advanced endoscopy system ELUXEO 8000 in Europe.
  • March 2024: Fujifilm gained 510(k) clearance from FDA for AI detection system CAD EYE for endoscopic imaging, enabling real-time detection and removal of colonic mucosal lesions.
  • March 2024: NTT Corporation and Olympus Corporation initiated joint demonstration of cloud-based endoscopy system leveraging IOWN APN technology for real-time cloud image processing.
  • January 2025: Karl Storz acquired its Swiss distributor ANKLIN, strengthening direct sales and customer service in Switzerland.
  • January 2025: Stryker Corporation reported Q4 2024 net sales growth of 10.7% to $6.4 billion, with full-year sales of $22.6 billion and strong performance across MedSurg segment.
  • January 2024: ANX Robotica received FDA approval for CapsuleX system, AI-powered endoscopy tool designed to enhance small bowel imaging and improve diagnostic accuracy in gastrointestinal care.
  • January 2024: Olympus acquired Taewoong Medical Co., Ltd. (Korea), expanding its GI Endo Therapy portfolio.
  • December 2022: Olympus Corporation signed agreement to acquire Odin Vision, London-based cloud-AI endoscopy company, transforming procedural and clinical workflows.
  • November 2023: Ambu received 510(k) regulatory clearance from U.S. FDA for ureteroscopy solution including aScope 5 Uretero single-use ureteroscope and aBox 2 full-HD endoscopy system.
  • October 2023: Olympus Corporation initiated commercialization of EVIS X1 Endoscopy System in United States, announced at American College of Gastroenterology annual meeting.
  • February 2023: Boston Scientific received FDA clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System for kidney stone procedures.
  • February 2022: Medtronic collaborated with American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved U.S. communities.

Key Players

  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Boston Scientific Corporation
  • Medtronic plc
  • Stryker Corporation
  • FUJIFILM Holdings Corporation
  • Johnson & Johnson (Ethicon Endo-Surgery)
  • HOYA Corporation (PENTAX Medical)
  • Smith & Nephew plc
  • Richard Wolf GmbH
  • Intuitive Surgical, Inc.
  • Cook Medical
  • ConMed Corporation
  • B. Braun Melsungen AG
  • Ambu A/S
  • Teleflex Incorporated
  • Carl Zeiss AG
  • Arthrex, Inc.
  • The Cooper Companies, Inc.
  • Laborie Medical Technologies Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=3835&flag=C

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302